The state of Texas currently has 14 active clinical trials seeking participants for Pulmonary Fibrosis research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Recruiting
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants with PPF over 52 weeks.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/23/2025
Locations: Baylor Scott & White Research Institute, Baylor University Medical Center, Dallas, Texas +4 locations
Conditions: Progressive Pulmonary Fibrosis
A Study to Investigate Leramistat in Patients With IPF
Recruiting
To compare the effect of daily oral dosing of leramistat over 12 weeks with placebo in participants aged 40 years or older with idiopathic pulmonary fibrosis (IPF).
Gender:
ALL
Ages:
40 years and above
Trial Updated:
02/16/2024
Locations: Baylor Scott and White Health - Advanced Lung Disease Specialists - Dallas, Dallas, Texas +2 locations
Conditions: Idiopathic Pulmonary Fibrosis